This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2004 Jul 28;292(4):419-22.

doi: 10.1001/jama.292.4.419.

"Promiscuous" anticancer drugs that hit multiple targets may thwart resistance

PMID: 15280324
DOI: 10.1001/jama.292.4.419

"Promiscuous" anticancer drugs that hit multiple targets may thwart resistance

Tracy Hampton. JAMA. 2004.

. 2004 Jul 28;292(4):419-22.

doi: 10.1001/jama.292.4.419.

Author

PMID: 15280324
DOI: 10.1001/jama.292.4.419

No abstract available

PubMed Disclaimer

Similar articles

Phosphatases as targets for cancer treatment.
Lazo JS, Wipf P. Lazo JS, et al. Curr Opin Investig Drugs. 2009 Dec;10(12):1297-304. Curr Opin Investig Drugs. 2009. PMID: 19943201 Review.
Receptorome screening: a powerful, facile approach to better understand and engineer drugs.
Setola V. Setola V. Drug News Perspect. 2009 Oct;22(8):459-66. Drug News Perspect. 2009. PMID: 20016855 Review.
RITA--a small-molecule anticancer drug that targets p53.
Doggrell SA. Doggrell SA. Expert Opin Investig Drugs. 2005 Jun;14(6):739-42. doi: 10.1517/13543784.14.6.739. Expert Opin Investig Drugs. 2005. PMID: 16004600 Review. No abstract available.
Ubiquitin Drug Discovery & Diagnostics 2009 - First Annual Conference.
Marblestone JG. Marblestone JG. IDrugs. 2009 Dec;12(12):750-3. IDrugs. 2009. PMID: 19943215
American Association for Cancer Research--100th Annual Meeting. New therapeutic developments: part 2. 18-22 April 2009, Denver, CO, USA.
Gale S, McGee V, Lee W. Gale S, et al. IDrugs. 2009 Jun;12(6):335-8. IDrugs. 2009. PMID: 19517309 No abstract available.

See all similar articles

Cited by

Simple di- and trivanillates exhibit cytostatic properties toward cancer cells resistant to pro-apoptotic stimuli.
Lamoral-Theys D, Pottier L, Kerff F, Dufrasne F, Proutière F, Wauthoz N, Neven P, Ingrassia L, Antwerpen PV, Lefranc F, Gelbcke M, Pirotte B, Kraus JL, Nève J, Kornienko A, Kiss R, Dubois J. Lamoral-Theys D, et al. Bioorg Med Chem. 2010 Jun 1;18(11):3823-33. doi: 10.1016/j.bmc.2010.04.047. Epub 2010 Apr 21. Bioorg Med Chem. 2010. PMID: 20466556 Free PMC article.
Promiscuous drugs compared to selective drugs (promiscuity can be a virtue).
Mencher SK, Wang LG. Mencher SK, et al. BMC Clin Pharmacol. 2005 Apr 26;5:3. doi: 10.1186/1472-6904-5-3. BMC Clin Pharmacol. 2005. PMID: 15854222 Free PMC article. Review.
Data driven polypharmacological drug design for lung cancer: analyses for targeting ALK, MET, and EGFR.
Narayanan D, Gani OABSM, Gruber FXE, Engh RA. Narayanan D, et al. J Cheminform. 2017 Jul 4;9(1):43. doi: 10.1186/s13321-017-0229-8. J Cheminform. 2017. PMID: 29086093 Free PMC article.
IC261 induces cell cycle arrest and apoptosis of human cancer cells via CK1δ/ɛ and Wnt/β-catenin independent inhibition of mitotic spindle formation.
Cheong JK, Nguyen TH, Wang H, Tan P, Voorhoeve PM, Lee SH, Virshup DM. Cheong JK, et al. Oncogene. 2011 Jun 2;30(22):2558-69. doi: 10.1038/onc.2010.627. Epub 2011 Jan 24. Oncogene. 2011. PMID: 21258417 Free PMC article.
Distribution patterns of small-molecule ligands in the protein universe and implications for origin of life and drug discovery.
Ji HF, Kong DX, Shen L, Chen LL, Ma BG, Zhang HY. Ji HF, et al. Genome Biol. 2007;8(8):R176. doi: 10.1186/gb-2007-8-8-r176. Genome Biol. 2007. PMID: 17727706 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- The Lens - Patent Citations Database